Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Benlysta – Lupus Treatment

Drug (brand / generic)

Benlysta (belimumab)

Company / Licence

Human Genome Sciences developed with GlaxoSmithKline

Therapy Class

Monoclonal antibody therapy

Product Description

Immunosuppressant

Current Indication

Systemic Lupus Erythematosus (fatal or chronic autoimmune disorder)

Market Sector

Immune system

Development Status

Approved in US
Expand
Close
Close
Close

Go Top